Inventor
Steven J. Prestrelski
Inventor
San Diego, CA, US
Overview
Patents· 30 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes45%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations34%
C07KPeptides9%
A61MDevices for introducing media into, or onto, the body7%
A61FFilters implantable into blood vessels1%
C12YEnzymes1%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1%
PatentTitleYear
11,020,403Precipitation resistant small molecule drug formulations202110,987,399Stable formulations for parenteral injection of peptide drugs202110,765,683Stable formulations for parenteral injection of small molecule drugs202010,485,850Methods for producing stable therapeutic formulations in aprotic polar solvents20199,687,527'Stable glucagon formulations for the treatment of hypoglycemia'20179,649,364'Methods for producing stable therapeutic formulations in aprotic polar solvents'20179,642,894'Compositions for rapidly treating severe hypoglycemia'20179,339,545'Stable formulations for parenteral injection of peptide drugs'20169,314,424'Pastes for injection of a therapeutic agent'20169,302,010'Stable formulations for parenteral injection of peptide drugs'20169,295,724'Stable formulations for parenteral injection of peptide drugs'20169,138,479'Formulations for the treatment of diabetes'20159,125,805'Stable formulations for parenteral injection of small molecule drugs'20159,018,162'Methods for rapidly treating severe hypoglycemia'20158,790,679'Intracutaneous paste composition'20148,697,644'Stable formulations for parenteral injection of peptide drugs'20148,110,209'Intracutaneous injection'20127,229,645'Spray freeze-dried compositions'20077,022,313'Hydrogel particle formulation'20066,730,328'Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity'20046,264,990'Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity.'20016,235,712'Non-aqueous polar aprotic peptide formulations'20016,124,261'Non-aqueous polar aprotic peptide formulations'20006,068,850'Aqueous formulations of peptides'20006,066,619'Non-aqueous protic peptide formulations'20005,981,489'Non-aqueous protic peptide formulations'19995,972,369'Diffusional implantable delivery system'19995,932,547'Non-aqueous polar aprotic peptide formulations'19995,916,582'Aqueous formulations of peptides'19995,580,856'Formulation of a reconstituted protein, and method and kit for the production thereof'1996Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1996–2014Based in Mountain View, CA, US· patent location history
1999–2001Patents assigned to ALZA CORP (9)· patent assignee history
2007Based in Fremont, CA, US· patent location history
2012–2021Patents assigned to XERIS PHARMACEUTICALS INC (17)· patent assignee history
2012–2017Patents assigned to PRESTRELSKI STEVEN (4)· patent assignee history
2012–2014Patents assigned to BRODBECK KEVIN (2)· patent assignee history
2014–2017Patents assigned to KINZELL JOHN (2)· patent assignee history
2014–2021Based in San Diego, CA, US· patent location history
2019Based in Chicago, IL, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| XERIS PHARMACEUTICALS INC | 17 | 2012–2021 |
| ALZA CORP | 9 | 1999–2001 |
| PRESTRELSKI STEVENself | 4 | 2012–2017 |
| BRODBECK KEVIN | 2 | 2012–2014 |
| KINZELL JOHN | 2 | 2014–2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 14 | 2014–2021 |
| Mountain View, California, US | 14 | 1996–2014 |
| Chicago, Illinois, US | 1 | 2019 |
| Fremont, California, US | 1 | 2007 |